Trials (King Albert II Cancer Institute): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
<span style="display:none">forproviders</span> | <span style="display:none">forproviders</span> | ||
<span style="display:none">forresearchers</span> | <span style="display:none">forresearchers</span> | ||
<span style="display:none"> | <span style="display:none">belgiumcountry</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
Revision as of 14:09, 14 December 2025
Go back to King Albert II Cancer Institute page
Trials: How to participate
Contact information: Click here to access.
